Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Tuberculosis

Free Subscription Articles published in Emerg Infect Dis Retrieve available abstracts of 50 articles: HTML format

Single Articles

September 2026
1. ZUBAIRI R
   Recent Mycobacterium tuberculosis Transmission, United States, 2018-2022.
   Emerg Infect Dis. 2026;32:1531.
   PubMed    
   
   
   
2. FRANCO D, Panetta L, Ader F, Ouziel A, et al
   Pediatric Tuberculosis Care Outcomes in a Tertiary Care Center, France, 2014-2024.
   Emerg Infect Dis. 2026;32:1511-1513.
   PubMed     Abstract available
   
   
   
3. KAMMERER S
   Recent Mycobacterium tuberculosis Transmission, United States, 2018-2022 (Response).
   Emerg Infect Dis. 2026;32:1531-1532.
   PubMed    
   
   
   
4. AINIWAER A, Uppal A, Schwartzman K, Romanowski K, et al
   Posttuberculosis Consequences on Tuberculosis Prevention Effectiveness and Cost-effectiveness among New Immigrants, Canada.
   Emerg Infect Dis. 2026;32:1421-1429.
   PubMed     Abstract available
   
   
   August 2026
5. TEMPLIN L, Varajidas Y, Respeito D, Zindoga P, et al
   Tuberculosis after Preventive Therapy in Persons Living with HIV Initiating Antiretroviral Therapy (Response).
   Emerg Infect Dis. 2026;32:1383.
   PubMed    
   
   
   
6. CHEN Q
   Tuberculosis after Preventive Therapy in Persons Living with HIV Initiating Antiretroviral Therapy.
   Emerg Infect Dis. 2026;32:1382-1383.
   PubMed    
   
   
   June 2026
7. KAMMERER S, Flanagan D, Raz K, Shaw T, et al
   Characteristics of Plausible Source Cases Responsible for Recent Mycobacterium tuberculosis Transmission, United States, 2018-2022.
   Emerg Infect Dis. 2026;32:880-893.
   PubMed     Abstract available
   
   
   April 2026
8. WANG R, Huang CC, Becerra MC, Calderon RI, et al
   Transmissibility and Disease Progression of Asymptomatic Mycobacterium tuberculosis Infection, Lima, Peru.
   Emerg Infect Dis. 2026;32.
   PubMed     Abstract available
   
   
   March 2026
9. PUVIANI FC, Zaffagnini A, Mazzi C, Cirillo DM, et al
   Query into Tuberculosis Infection Screening and Management among Pregnant Migrants, Europe.
   Emerg Infect Dis. 2026;32:469-471.
   PubMed     Abstract available
   
   
   
10. POIGNON C, Vandenbos F, Risso K, Viard D, et al
    Occupational Transmission of Extensively Drug-Resistant Tuberculosis, France.
    Emerg Infect Dis. 2026;32:449-451.
    PubMed     Abstract available
    
    
    
11. AHSON M, Shah D, Bhide S, Deshmukh R, et al
    Home-Based Monitoring of Treatment-Related Adverse Events during Drug-Resistant Tuberculosis Treatment, India, 2020-2024.
    Emerg Infect Dis. 2026;32:419-423.
    PubMed     Abstract available
    
    
    
12. TEMPLIN L, Varajidas Y, Respeito D, Zindoga P, et al
    Tuberculosis after TB Preventive Therapy in Persons Living with HIV Recently Initiating Antiretroviral Therapy, Mozambique.
    Emerg Infect Dis. 2026;32:409-413.
    PubMed     Abstract available
    
    
    
13. FENG PI, Phares CR, Pratt R, Self JL, et al
    Tuberculosis before and during COVID-19 Pandemic, United States, 2010-2023.
    Emerg Infect Dis. 2026;32:388-396.
    PubMed     Abstract available
    
    
    
14. MACHADO M, Jordan AE, Schwalb A, Houben RMGJ, et al
    Projected Effects of Changing Global Tuberculosis Epidemiology on Mycobacterium tuberculosis Immunoreactivity Prevalence, 2024-2050.
    Emerg Infect Dis. 2026;32:332-340.
    PubMed     Abstract available
    
    
    December 2025
15. KURBATOVA EV, Whitworth WC, Bryant KE, Dixon MG, et al
    Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020.
    Emerg Infect Dis. 2025;31:2233-2242.
    PubMed     Abstract available
    
    
    November 2025
16. SEUNG KJ, Asfaw M, Kunda M, Maama-Maime LB, et al
    Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho.
    Emerg Infect Dis. 2025;31:2185-2187.
    PubMed     Abstract available
    
    
    October 2025
17. GUO C, Pan Y, Yu J, Yao L, et al
    Disseminated Blastomycosis Mimicking Tuberculosis, China.
    Emerg Infect Dis. 2025;31:2046-2048.
    PubMed     Abstract available
    
    
    July 2025
18. ROY A, Gomez-Barroso D, Cruz-Ferro E, Fernandez A, et al
    Spatiotemporal Distribution and Clinical Characteristics of Zoonotic Tuberculosis, Spain, 2018-2022.
    Emerg Infect Dis. 2025;31:1344-1352.
    PubMed     Abstract available
    
    
    
19. ASAY GRB, Young KH, Hill TD, Njie GJ, et al
    Systematic Review of Contact Investigation Costs for Tuberculosis, United States.
    Emerg Infect Dis. 2025;31:1284-1293.
    PubMed     Abstract available
    
    
    March 2025
20. PAUL R, Lorenzo F, Lopez B, Alegre MG, et al
    Outbreak Caused by Multidrug-Resistant Mycobacterium Tuberculosis with Unusual Combination of Resistance Mutations, Northern Argentina, 2006-2022.
    Emerg Infect Dis. 2025;31:601-606.
    PubMed     Abstract available
    
    
    
21. KLINKENBERG E, de Haas P, Manyonge C, Namutebi J, et al
    Lessons Learned from Early Implementation and Scale-up of Stool-Based Xpert Testing to Diagnose Tuberculosis in Children.
    Emerg Infect Dis. 2025;31:1-9.
    PubMed     Abstract available
    
    
    
22. GERUSSI V, Petersen T, Bonnet I, Aubry A, et al
    Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment.
    Emerg Infect Dis. 2025;31:633-636.
    PubMed     Abstract available
    
    
    
23. FRANCISCO NM, Gaviraghi A, Alladio F, Huits R, et al
    Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, Angola.
    Emerg Infect Dis. 2025;31:627-629.
    PubMed     Abstract available
    
    
    
24. KONSTANTYNOVSKA O, Synenko T, Honcharenko A, Volobuieva O, et al
    Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019-2023.
    Emerg Infect Dis. 2025;31:615-617.
    PubMed     Abstract available
    
    
    
25. JUNG E, Alarcon VA, Solis Tupes WS, Avalos-Cruz T, et al
    National Active Case-Finding Program for Tuberculosis in Prisons, Peru, 2024.
    Emerg Infect Dis. 2025;31:564-568.
    PubMed     Abstract available
    
    
    
26. SHRESTHA S, Cilloni L, Asay GRB, Kammerer JS, et al
    Model-Based Analysis of Impact, Costs, and Cost-effectiveness of Tuberculosis Outbreak Investigations, United States.
    Emerg Infect Dis. 2025;31:497-506.
    PubMed     Abstract available
    
    
    
27. ZIMENKOV D, Ushtanit A, Gordeeva E, Guselnikova E, et al
    High Prevalence of atpE Mutations in Bedaquiline-Resistant Mycobacterium tuberculosis Isolates, Russia.
    Emerg Infect Dis. 2025;31:525-536.
    PubMed     Abstract available
    
    
    
28. KURBATOVA EV, Whitworth WC, Peddareddy LP, Phillips PPJ, et al
    Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes.
    Emerg Infect Dis. 2025;31:467-476.
    PubMed     Abstract available
    
    
    November 2024
29. GORVETZIAN S, Pacheco AG, Anderson E, Ray SM, et al
    Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008-2019.
    Emerg Infect Dis. 2024;30:2261-2270.
    PubMed     Abstract available
    
    
    August 2024
30. MCQUAID CF, Ryckman TS, Menzies NA, White RG, et al
    Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance.
    Emerg Infect Dis. 2024;30:1571-1579.
    PubMed     Abstract available
    
    
    July 2024
31. LUKOYE D, Kalamya JN, Awor AC, Gustavson G, et al
    Treatment Outcomes for Tuberculosis Infection and Disease Among Persons Deprived of Liberty, Uganda, 2020.
    Emerg Infect Dis. 2024;30:1402-1405.
    PubMed     Abstract available
    
    
    June 2024
32. TAN Q, Huang CC, Becerra MC, Calderon R, et al
    Chest Radiograph Screening for Detecting Subclinical Tuberculosis in Asymptomatic Household Contacts, Peru.
    Emerg Infect Dis. 2024;30:1115-1124.
    PubMed     Abstract available
    
    
    April 2024
33. FUKUNAGA R, Pierre P, Williams JK, Briceno-Robaugh R, et al
    Prioritizing Mental Health within HIV and Tuberculosis Services in PEPFAR.
    Emerg Infect Dis. 2024;30:1-5.
    PubMed     Abstract available
    
    
    
34. DAHL VN, Butova T, Rosenthal A, Grinev A, et al
    Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017-2022.
    Emerg Infect Dis. 2024;30:831-833.
    PubMed     Abstract available
    
    
    
35. GURREY SO, Strick LB, Dov LK, Miller JS, et al
    Lessons Learned from Public Health and State Prison Collaborations during COVID-19 Pandemic and Multifacility Tuberculosis Outbreak, Washington, USA.
    Emerg Infect Dis. 2024;30:S17-S20.
    PubMed     Abstract available
    
    
    March 2024
36. SPIES R, Hong HN, Trieu PP, Lan LK, et al
    Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of Tuberculosis, Ho Chi Minh City, Vietnam, 2020-2023.
    Emerg Infect Dis. 2024;30:499-509.
    PubMed     Abstract available
    
    
    
37. GUNTHER G, Mhuulu L, Diergaardt A, Dreyer V, et al
    Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia.
    Emerg Infect Dis. 2024;30:568-571.
    PubMed     Abstract available
    
    
    January 2024
38. HAN E, Nabity SA, Dasgupta-Tsinikas S, Guevara RE, et al
    Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020.
    Emerg Infect Dis. 2024;30:136-140.
    PubMed     Abstract available
    
    
    
39. HUMAYUN M, Mukasa L, Ye W, Bates JH, et al
    Racial and Ethnic Disparities in Tuberculosis Incidence, Arkansas, USA, 2010-2021.
    Emerg Infect Dis. 2024;30:116-124.
    PubMed     Abstract available
    
    
    
40. NSENGIYUMVA NP, Khan A, Gler MMTS, Tonquin ML, et al
    Costs of Digital Adherence Technologies for Tuberculosis Treatment Support, 2018-2021.
    Emerg Infect Dis. 2024;30:79-88.
    PubMed     Abstract available
    
    
    December 2023
41. LAFLEUR M, Rasoanaivo HA, Andrianarivo TH, Andrianomanana FR, et al
    Tuberculosis in Lemurs and a Fossa at National Zoo, Madagascar, 2022.
    Emerg Infect Dis. 2023;29:2587-2589.
    PubMed     Abstract available
    
    
    November 2023
42. MODONGO C, Barilar I, Wang Q, Molefi T, et al
    Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana.
    Emerg Infect Dis. 2023;29:2403-2406.
    PubMed     Abstract available
    
    
    October 2023
43. WINSTON CA, Marks SM, Carr W
    Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States.
    Emerg Infect Dis. 2023;29:2102-2104.
    PubMed     Abstract available
    
    
    August 2023
44. NABITY SA, Marks SM, Goswami ND, Smith SR, et al
    Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available
    
    
    
45. LOUIE JK, Agraz-Lara R, Romo L, Deiterich C, et al
    Uniting for Ukraine Tuberculosis Screening Experience, San Francisco, California, USA.
    Emerg Infect Dis. 2023;29:1651-1654.
    PubMed     Abstract available
    
    
    July 2023
46. WOODRUFF R, Miramontes R
    Tuberculosis Infection among Non-US-Born Persons and Persons >/=60 Years of Age, United States, 2019-2020.
    Emerg Infect Dis. 2023;29:1470-1472.
    PubMed     Abstract available
    
    
    May 2023
47. NOROC E, Chesov D, Merker M, Groschel MI, et al
    Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova.
    Emerg Infect Dis. 2023;29:1046-1050.
    PubMed     Abstract available
    
    
    
48. NGUYEN HV, Brals D, Tiemersma E, Gasior R, et al
    Influence of Sex and Sex-Based Disparities on Prevalent Tuberculosis, Vietnam, 2017-2018.
    Emerg Infect Dis. 2023;29:967-976.
    PubMed     Abstract available
    
    
    
49. BAKER CR, Barilar I, de Araujo LS, Rimoin AW, et al
    Use of High-Resolution Geospatial and Genomic Data to Characterize Recent Tuberculosis Transmission, Botswana.
    Emerg Infect Dis. 2023;29:977-987.
    PubMed     Abstract available
    
    
    
50. MILLARD J, Rimmer S, Nimmo C, O'Donnell M, et al
    Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB.
    Emerg Infect Dis. 2023;29:1081-1084.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum